[1]
J. Liu, Z. Wang, F. Li, J. Gao, L. Wang, G. Huang, Liposomes for systematic delivery of vancomycin hydrochloride to decrease nephrotoxicity: Characterization and evaluation, Asian J. Pharm. Sci. 10 (2015) 212–222.
DOI: 10.1016/j.ajps.2014.12.004
Google Scholar
[2]
Z. Yang, J. Liu, J. Gao, S. Chen, G. Huang, Chitosan coated vancomycin hydrochloride liposomes: Characterizations and evaluation, Int. J. Pharm. 495 (2015) 508–515.
DOI: 10.1016/j.ijpharm.2015.08.085
Google Scholar
[3]
N. Karami, E. Moghimipour, A. Salimi, Liposomes as a novel drug delivery system: fundamental and pharmaceutical application, Asian J. Pharm. 12 (2018) 31–41.
Google Scholar
[4]
A. Gonzalez Gomez, S. Syed, K. Marshall, Z. Hosseinidoust, Liposomal nanovesicles for efficient encapsulation of staphylococcal antibiotics, Am. Chem. Soc. Omega. 4 (2019) 10866–10876.
DOI: 10.1021/acsomega.9b00825
Google Scholar
[5]
A. Samad, Y. Sultana, M. Aqil, Liposomal drug delivery systems: an update review, Curr. Drug Deliv. 4 (2007) 297–305.
DOI: 10.2174/156720107782151269
Google Scholar
[6]
Z. Kavrakovski, O. Popovska, J. Simonovska, Z. Kavrakovski, V. Rafajlovska, An overview: methods for preparation and characterization of liposomes as drug delivery systems, Int. J. Pharm. Phytopharm. Res. 3 (2013) 182–189.
DOI: 10.5530/ijper.54.4.188
Google Scholar
[7]
V.V. Ranade, A.M. Hollinger, Drug delivery systems, Second Edi, CRC Press LLC, (2004).
Google Scholar
[8]
R.P. Singh, H. V. Gangadharappa, K. Mruthunjaya, Phospholipids: unique carriers for drug delivery systems, J. Drug Deliv. Sci. Technol. 39 (2017) 166–179.
DOI: 10.1016/j.jddst.2017.03.027
Google Scholar
[9]
A.G. Kohli, P.H. Kierstead, V.J. Venditto, C.L. Walsh, F.C. Szoka, Designer lipids for drug delivery: From heads to tails, J. Control. Release. 190 (2014) 274–287.
DOI: 10.1016/j.jconrel.2014.04.047
Google Scholar
[10]
D. Thassu, M. Deleers, Y. Pathak, Nanoparticulate drug delivery systems, Informa Healthcare USA, Inc., New York, (2007).
DOI: 10.1201/9781420008449-13
Google Scholar
[11]
M. Anderson, A. Omri, The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations, Drug Deliv. 11 (2004) 33–39.
DOI: 10.1080/10717540490265243
Google Scholar
[12]
A. V. Yadav, M.S. Murthy, A.S. Shete, S. Sakhare, Stability aspects of liposomes, Indian J. Pharm. Educ. Res. 45 (2011) 402–413.
Google Scholar
[13]
J.O. Eloy, M. Claro de Souza, R. Petrilli, J.P.A. Barcellos, R.J. Lee, J.M. Marchetti, Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery, Colloids Surfaces B Biointerfaces. 123 (2014) 345–363.
DOI: 10.1016/j.colsurfb.2014.09.029
Google Scholar
[14]
S. Ohtake, C. Schebor, S.P. Palecek, J.J. De Pablo, Phase behavior of freeze-dried phospholipid-cholesterol mixtures stabilized with trehalose, Biochim. Biophys. Acta. 1713 (2005) 57–64.
DOI: 10.1016/j.bbamem.2005.05.001
Google Scholar
[15]
J. H Martin, R. Norris, M. Barras, J. Roberts, R. Morris, D. Matthew, J. Graham RD, Therapeutic monitoring of vancomycin in adults: Summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists, Clin. Biochem. Rev. 31 (2010) 21–24.
DOI: 10.3410/f.13484981.14862100
Google Scholar
